US Patent 9840516 Substituted quinazolines as inhibitors of KRAS G12C

Is a

Patent

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

98405160

Patent Inventor Names

Tao Wu0

Jun Feng0

Liansheng Li0

Pingda Ren0

Yi Liu0

Yuan Liu0

Yun Oliver Long0

Date of Patent

December 12, 2017

Patent Application Number

145114250

Date Filed

October 10, 2014

Patent Citations Received

‌

US Patent 11932633 KRas G12C inhibitors

‌

US Patent 11964989 KRas G12D inhibitors

‌

US Patent 12065430 Indazole compound or salt thereof

‌

US Patent 12134620 Heterocyclic spiro compounds and methods of use thereof for the treatment of cancer

‌

US Patent 11702418 SOS1 inhibitors

‌

US Patent 12084429 Fused ring compounds

‌

US Patent 11697657 Small molecule inhibitors of KRAS G12C mutant

‌

US Patent 12122787 Fused pyridone compound, and preparation method therefor and use thereof

...

Patent Primary Examiner

‌

Douglas M Willis

Patent abstract

Compounds having activity as inhibitors of G12C mutant KRAS protein are provided. The compounds have the following structure (I):

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 9840516 Substituted quinazolines as inhibitors of KRAS G12C

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 9840516 Substituted quinazolines as inhibitors of KRAS G12C